Putative Natural History of CoViD-19.
Bioinformation
; 16(5): 398-403, 2020.
Article
in English
| MEDLINE | ID: covidwho-729741
ABSTRACT
The Severe Acute Respiratory Syndrome Corona Virus2 (SARS-CoV2) is responsible for Corona Virus Disease 2019 (CoViD-19), the pandemic that has afflicted close to two million people worldwide, and has taken the lives of over 120,000 patients since its first report in late December 2019. Per million people globally, the infection rate is close to 250 with a death rate of close to 14 (death rate average global death rate 6.06%; for comparison, revised estimate of the 1918 influenza pandemic had an average global death rate of 5.4% [1]). About 400,000 SARS-CoV2-positive patients have been declared 'recovered', although it is not clear to date what exactly that entails. To be clear, the natural history of SARS-CoV2 infection and of the patho-physiology of CoViD-19 remains shrouded in relative confusion, in part due to the exceedingly virulent nature of the virus, as manifest by its elevated morbidity and mortality, and the fast accumulation of clinical observations and research evidence. Many pieces of a complex puzzle are emerging all at once and their organization into a coherent and cogent picture of the natural history of CoViD-19 is arduous and still wanting. Here, we discuss the recent findings in the context of the available evidence. We propose a putative prediction model of the natural history of CoViD-19. We highlight putative loci and modes of therapeutic intervention that may become beneficial preventive and treatment modalities for individuals at risk of SARS-CoV2 infection and CoViD-19 patients.
Basigin CD147; Corona Virus Disease 2019 (CoViD-19); Exopeptidase CD26; Peptidase Targeted Immunoregulation (PeTIr); Severe Acute Respiratory Syndrome Corona Virus2 (SARS-CoV2); angiotensin-converting enzyme-2 (ACE2); clustered regularly interspaced short palindromic repeats (CRISPR); cytokine synthesis inhibitory factor (IL10); platelet tissue factor CD142; transferrin receptor CD71; transmembrane protease serine-2 (TMPRSS2)
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
Bioinformation
Year:
2020
Document Type:
Article
Affiliation country:
97320630016398
Similar
MEDLINE
...
LILACS
LIS